The Europe animal vaccines market is poised to reach $2540.82 Million by 2020 from $1993.64 Million in 2015, at a CAGR of 4.97% from 2015 to 2020. Vaccination protects animals from specific infectious diseases and may be carried out either routinely or potentially in an emergency. Vaccination of animals used for food can also help protect consumers against zoonotic pathogens such as salmonella.



Veterinary vaccine market in Europe is as old as the concept itself and newest products are significantly available throughout the market. The farmers and animal husbandry owners seem well versed with the idea of animal vaccination. But the real test lies in the stringent guidelines for animal vaccines testing as per EU regulations. This prevents or at least hardens the route for new players to enter the market. Also the market has undergone considerable progress during the past few years with the growing usage of continuous cell lines as a substrate and embracing of the fermenter technology for antigen production. These vaccines are produced for administration by parenteral or oral routes depending on the vaccine characteristics.



Growing prevalence of animal diseases, rising incidences of zoonotic diseases in humans; increasing investments by leading players, various government agencies and animal associations; continuous innovations, increasing awareness against the use of antimicrobials is driving the vaccine producers to invest significantly into development of new products. However, rising maintenance costs for the storage of vaccines, increasing adoption of vegetarian diet in major economies owing to increasing risk of obesity and other chronic diseases are key restraints of this market.



The Europe veterinary vaccines market, based on production technologies, has been segmented as live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines. Further, based on Animal Type, it has been segmented into livestock and companion vaccines. The livestock vaccines segment contains five categories namely, bovine, porcine, ovine, poultry and equine. The bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine. The companion animal vaccines segment has also been further categorized into feline and canine vaccines. Similarly, the canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination. Furthermore, on the basis of geography, the European Market is analysed under various regions namely, UK, Spain, Italy, Germany and France. European region is leading the veterinary vaccine market in terms of consumption.



Some of the key players influencing the market are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Heath, Inc., Merck & Co. Inc, and Protein Sciences.